Skip to main content
European Commission logo print header

Human on Chip : Microsensor unit and control algorithm integration for brain on a chip drug testing applications and development

Ziel

"Cherry Biotech is an innovative French company which develops and commercializes microfluidic instruments for life sciences and healthcare. We position ourselves on a biological research market in which we are developing a range of tools dedicated to high resolution imaging. Other cellular environment control systems are also in test or development to support business growth. This technical base and the transversal skills held by the team has ideally positioned Cherry Biotech to carry out ambitious projects in the growing market of the Organs on a chip.
The design, development and implementation of microfluidic devices called ""Organ-on-a-Chip"" require the understanding and the integration of numerous components (technical, biological issues and constraints ...).
The candidate will take over from its genesis to the development of proof of concept the development of a microfluidic instrumentation platform to test therapeutic molecules on artificial organs (Brain) integrated within microfluidic chips. His challenge will be to integrate a complex technical environment (instrumentation, sensors, microfluidics) with important biological constraints.
"

Aufforderung zur Vorschlagseinreichung

H2020-INNOSUP-2016-2017

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-INNOSUP-02-2016

Koordinator

CHERRY BIOTECH
Netto-EU-Beitrag
€ 81 875,00
Adresse
2EME ETAGE, HALLS A-B ET C14 RUE DE LA BEAUNE
93100 Montreuil
Frankreich

Auf der Karte ansehen

KMU

Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen).

Ja
Region
Ile-de-France Ile-de-France Seine-Saint-Denis
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Gesamtkosten
€ 81 875,00